Cell damage and autoimmunity: A critical appraisal

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 5-11

  Mackay, Ian R ^a   Leskovsek, Natasha V ^b   Rose, Noel R ^c,d  

^a MONASH UNIVERSITY   (Australia)

^b American Autoimmune Related Diseases Association Inc   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Apoptosis; Autoimmunity; Cell damage; Environmental exposure; Genetics; Infection; Inflammation

Indexed keywords

AUTOANTIBODY;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BETA HEMOLYTIC STREPTOCOCCUS; CELL DAMAGE; ENVIRONMENTAL EXPOSURE; EPSTEIN BARR VIRUS; GASTRITIS; GENETICS; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN; IMMUNE SYSTEM; INFECTION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE; MICROORGANISM; POPULATION; PRIORITY JOURNAL; REVIEW; RHEUMATIC HEART DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION;

APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFECTION; INFLAMMATION;

EID: 38049078520     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.009     Document Type: Review

References (88)

1. Gavin A.L., Hoebe K., Duong B., Ota T., Martin C., Beutler B., et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314 (2006) 1936-1938
2. Fairweather D., Frisancho-Kiss S., and Rose N.R. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 15 (2005) 17-27
3. Mackay I.R. Cameos. In: Rose N.R., and Mackay I.R. (Eds). The autoimmune diseases (2006), Elsevier Academic Press, San Diego, CA, USA 995-1008
4. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347 (2002) 911-920
5. Guilherme L., Ramasawmy R., and Kalil J. Rheumatic fever and rheumatic hear disease: genetics and pathogenesis. Scand J Immunol 66 (2007) 199-207
6. Yuki N. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: the Guillain-Barré syndrome. Cell Mol Life Sci 57 (2000) 527-533
7. Rose N.R., and Mackay I.R. Molecular mimicry: a critical look at exemplary instances is human disease. Cell Mol Life Sci 57 (2000) 542-551
8. Lasky T., Terracciano G.J., Magder L., Koski C.L., Ballesteros M., Nash D., et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 339 (1998) 1797-1802
9. Uibo R. Contribution of epidemiological studies to gastritis immunology. Int Rev Immunol 24 (2005) 31-54
10. Clancy R.M., Neufing P.J., Zheng P., O'Mahony M., Nimmerjahn F., Gordon T.P., et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heard block. J Clin Invest 116 (2006) 2413-2422
11. 1-antirypsin protects beta-cells from apoptosis. Diabetes 56 (2007) 316-323
12. Green P.H., and Cellier C. Celiac disease. N Engl J Med 357 (2007) 1731-1743
13. Bizzaro N. Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev 6 (2007) 325-333
14. Chan E.K., Fritzler M.J., Wiik A., Andrade L.E., Reeves W.H., Tincani A., et al. AutoAbSC.Org - Autoantibody Standardization Committee in 2006. Autoimmun Rev 6 (2007) 577-580
15. Rieger R., and Gershwin M.E. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28 (2007) 76-84
16. Rose N.R., Bonita R., and Burek C.L. Iodine: an environmental trigger of thyroiditis. Autoimmun Rev 1 (2002) 97-103
17. Christensen K., and Murray J.C. What genome-wide association studies can do for medicine. N Engl J Med 356 (2007) 1094-1097
18. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
19. Li H, Rose NR. Genetic complexity of autoimmune myocarditis. Autoimmun Rev, in press.
20. Lee Y.H., Rho P.A., Choi S.J., Song G.G., Nath S.K., and Harley J.B. The PTPN22 C1858T polymorphism and autoimmune disease - a meta-analysis. Rheumatology 46 1 (2007) 49-56
21. Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., Bennett D.C., et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356 (2007) 1216-1225
22. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357 (2007) 977-986
23. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357 (2007) 851-862
24. Chistiakov D.A., and Chistiakov A.P. Is FCRL3 a new general autoimmunity gene?. Hum Immunol 68 (2007) 375-383
25. Chen M., Huang L., and Wang J. Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 109 (2007) 4360-4367
26. Ballestar E., Esteller M., and Richardson B.C. The epigenetic face of systemic lupus erythematosus. J Immunol 176 (2006) 7143-7147
27. Matsumoto I., Maccioni M., Lee D.M., Maurice M., Simmons B., Brenner M., et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 3 (2002) 360-365
28. Allina J., Hu B., Sullivan D.M., Fiel M.I., Thung S.N., Bronk S.F., et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27 (2006) 232-241
29. Kowal C., Degiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 103 (2006) 19854-19859
30. Recalcati S., Invernizzi P., Arosio P., and Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30 (2008) 84-89
31. Andreoli L., Pregnolato F., Burlingame R., Allegri F., Rizzini S., Fanelli V., et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity. J Autoimmun 30 (2008) 51-57
32. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.-O., and Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 30 (2008) 63-67
33. Jacobson E., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 (2008) 58-62
34. Kallenberg C. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 (2008) 29-36
35. Nakanishi Y., Tsuneyama K., Fujimoto M., Thucydides L., Nomoto K., An J.-L., et al. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 30 (2008) 42-50
36. Poletaev A., Stepanyuk V., and Gershwin M. Integrating immunity: the immunculus and self reactivity. J Autoimmun 30 (2008) 68-73
37. Praprotnik S., Snezna S.-S., Tomsic M., and Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30 (2008) 37-41
38. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
39. Shoenfeld Y., and Gershwin M. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4
40. Akbarali Y., Matousek-Ronck J., Hunt L., Staudt L., Reichlin M., Guthridge J.M., et al. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. J Autoimmun 27 (2006) 272-280
41. Sharma R., Zheng L., Guo X., Fu S.M., Ju S.T., and Jarjour W.N. Novel animal models for Sjogren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. J Autoimmun 27 (2006) 289-296
42. Rosloniec E.F., Brandstetter T., Leyer S., Schwaiger F.W., and Nagy Z.A. Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models. J Autoimmun 27 (2006) 182-195
43. Ablin J.N., Shoenfeld Y., and Buskila D. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun 27 (2006) 145-152
44. Inaoki M., Echigo T., Hayashi H., Nagaoka T., Hasegawa M., Takehara K., et al. Decreased expression levels of CD22 and l-selectin on peripheral blood B lymphocytes from patients with bullous pemphigoid. J Autoimmun 27 (2006) 196-202
45. Awdeh Z.L., Yunis E.J., Audeh M.J., Fici D., Pugliese A., Larsen C.E., et al. A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 27 (2006) 174-181
46. Wandstrat A.E., Carr-Johnson F., Branch V., Gray H., Fairhurst A.M., Reimold A., et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 27 (2006) 153-160
47. Barral A.M., Thomas H.E., Ling E.M., Darwiche R., Rodrigo E., Christen U., et al. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. J Autoimmun 27 (2006) 166-173
48. Toubi E., Gordon S., Kessel A., Rosner I., Rozenbaum M., Shoenfeld Y., et al. Elevated serum B-lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 27 (2006) 134-139
49. Alper C.A., Husain Z., Larsen C.E., Dubey D.P., Stein R., Day C., et al. Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun 27 (2006) 89-95
50. Gleicher N., Weiner R., and Vietzke M. The impact of abnormal autoimmune function on reproduction: maternal and fetal consequences. J Autoimmun 27 (2006) 161-165
51. Bjornvold M., Amundsen S.S., Stene L.C., Joner G., Dahl-Jorgensen K., Njolstad P.R., et al. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J Autoimmun 27 (2006) 140-144
52. Zlacka D., Vavrincova P., Hien Nguyen T.T., and Hromadnikova I. Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis. J Autoimmun 27 (2006) 81-88
53. Wu J.F., Yang Y.H., Wang L.C., Lee J.H., Shen E.Y., and Chiang B.L. Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus. J Autoimmun 27 (2006) 119-124
54. Aoki C.A., Roifman C.M., Lian Z.X., Bowlus C.L., Norman G.L., Shoenfeld Y., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27 (2006) 50-53
55. Gupta B., Raghav S.K., Agrawal C., Chaturvedi V.P., Das R.H., and Das H.R. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance. J Autoimmun 27 (2006) 125-133
56. Rieger R., Leung P.S., Jeddeloh M.R., Kurth M.J., Nantz M.H., Lam K.S., et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 27 (2006) 7-16
57. Sisto M., Lisi S., Castellana D., Scagliusi P., D'Amore M., Caprio S., et al. Autoantibodies from Sjogren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J Autoimmun 27 (2006) 38-49
58. Chin M.S., Caruso R.C., Detrick B., and Hooks J.J. Autoantibodies to p75/LEDGF, a cell survival factor, found in patients with atypical retinal degeneration. J Autoimmun 27 (2006) 17-27
59. Hu P.Q., Oppenheim J.J., Medsger Jr. T.A., and Wright T.M. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I. J Autoimmun 26 (2006) 258-267
60. Holzer U., Rieck M., and Buckner J.H. Lineage and signal strength determine the inhibitory effect of transforming growth factor beta1 (TGF-beta1) on human antigen-specific Th1 and Th2 memory cells. J Autoimmun 26 (2006) 241-251
61. O'Connor K.H., Banga J.P., Darmanin C., El-Kabbani O., Mackay I.R., and Rowley M.J. Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling. J Autoimmun 26 (2006) 172-181
62. Anaya J.M., Castiblanco J., Tobon G.J., Garcia J., Abad V., Cuervo H., et al. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 26 (2006) 208-214
63. Wu H.Y., Monsonego A., and Weiner H.L. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression. J Autoimmun 26 (2006) 116-126
64. Lapierre P., Beland K., Djilali-Saiah I., and Alvarez F. Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun 26 (2006) 82-89
65. Rivadeneyra-Espinoza L., and Ruiz-Arguelles A. Cell-penetrating anti-native DNA antibodies trigger apoptosis through both the neglect and programmed pathways. J Autoimmun 26 (2006) 52-56
66. Millet I., Wong F.S., Gurr W., Wen L., Zawalich W., Green E.A., et al. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes. J Autoimmun 26 (2006) 7-15
67. Nakamura M., Takii Y., Ito M., Komori A., Yokoyama T., Shimizu-Yoshida Y., et al. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. J Autoimmun 26 (2006) 138-145
68. Hallman T.M., Peng M., Meade R., Hancock W.W., Madaio M.P., and Gasser D.L. The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions. J Autoimmun 26 (2006) 1-6
69. Cross A.K., Haddock G., Surr J., Plumb J., Bunning R.A., Buttle D.J., et al. Differential expression of ADAMTS-1, -4, -5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis. J Autoimmun 26 (2006) 16-23
70. Morris G.P., and Kong Y.C. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J Autoimmun 26 (2006) 24-31
71. Goto N., Sugiura K., Ogawa Y., Watanabe A., Onouchi H., Tomita Y., et al. Anti-p80 coilin autoantibodies react with a conserved epitope and are associated with anti-DFS70/LEDGF autoantibodies. J Autoimmun 26 (2006) 42-51
72. Mizutori Y., Saitoh O., Eguchi K., and Nagayama Y. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice. J Autoimmun 26 (2006) 32-36
73. Borchers A.T., Selmi C., Cheema G., Keen C.L., Shoenfeld Y., and Gershwin M.E. Juvenile idiopathic arthritis. Autoimmun Rev 5 (2006) 279-298
74. Brandt D., and Gershwin M.E. Common variable immune deficiency and autoimmunity. Autoimmun Rev 5 (2006) 465-470
75. Chan A.T., Flossmann O., Mukhtyar C., Jayne D.R., and Luqmani R.A. The role of biologic therapies in the management of systemic vasculitis. Autoimmun Rev 5 (2006) 273-278
76. Chang X., Zheng P., and Liu Y. FoxP3: a genetic link between immunodeficiency and autoimmune diseases. Autoimmun Rev 5 (2006) 399-402
77. Chapman J. Thrombin in inflammatory brain diseases. Autoimmun Rev 5 (2006) 528-531
78. Chung L., and Fiorentino D. Digital ulcers in patients with systemic sclerosis. Autoimmun Rev 5 (2006) 125-128
79. Damoiseaux J.G., and Tervaert J.W. From ANA to ENA: how to proceed?. Autoimmun Rev 5 (2006) 10-17
80. Deshmukh U.S., Bagavant H., and Fu S.M. Role of anti-DNA antibodies in the pathogenesis of lupus nephritis. Autoimmun Rev 5 (2006) 414-418
81. Doria A., Sarzi-Puttini P., and Shoenfeld Y. 2nd conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005. Autoimmun Rev 5 (2006) 55-63
82. Duan B., and Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev 5 (2006) 403-408
83. Ichiki Y., Bowlus C.L., Shimoda S., Ishibashi H., Vierling J.M., and Gershwin M.E. T cell immunity and graft-versus-host disease (GVHD). Autoimmun Rev 5 (2006) 1-9
84. Knight A.K., and Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 5 (2006) 156-159
85. Kong J.S., Teuber S.S., and Gershwin M.E. Potential adverse events with biologic response modifiers. Autoimmun Rev 5 (2006) 471-485
86. Stojanovich L. Pulmonary manifestations in antiphospholipid syndrome. Autoimmun Rev 5 (2006) 344-348
87. Lleo A., Invernizzi P., Selmi C., Coppel R.L., Alpini G., Podda M., et al. Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29 (2007) 61-68
88. Lan R.Y., Mackay I.R., and Gershwin M.E. Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 29 (2007) 472-480